RENU 28 Effective At Treating Cellulite And Improving Skin Elasticity

SALT LAKE CITY, Sept. 14, 2015 /PRNewswire/ — ASEA, an emerging global leader in cellular health, today announced findings from a skin study conducted by leading dermatological research institute Dermatest. The study showed that RENU 28® skin gel effectively improves the appearance of cellulite as a result of the reduction of the size of adipose lobules. Additionally, the study showed significant improvement in skin elasticity.

In the study, 30 females aged 18 or older who had cellulite used RENU 28 twice a day for a 12 week period. In the cellulite test area, the use of ultrasound measurement showed improvement in the thickness and density of the skin. The measurements were performed in the same position and at the same sites before and after the 12 week in-use-period. The participants experienced a reduction of 15.81 percent in the appearance of cellulite, with the reduction in size of adipose lobules after the application period of 12 weeks.

“While other treatments for cellulite employ inflammation and the use of fillers for a temporary effect, RENU 28 works with the body’s natural cellular communication to actually reduce the adipose lobules,” said Charles F. Funke, ASEA Chief Executive Officer.

In the second test area, RENU 28 showed an increase in both the elasticity and hydration of the skin, both of which result in improved function and appearance of the skin. After the 12 weeks, researchers used a Cutometer sensor to measure the results and saw that the participants had an increase of 20.91 percent in skin elasticity. This is important given that with age, our skin loses its elasticity, or ability to bounce back to shape upon stretch, which results in the appearance of wrinkles.

“RENU 28 is active in redox signaling molecules that can be applied directly onto the skin to improve and revitalize it at the cellular level from the outside in,” said Dr. Karen Stolman, M.D. a board certified dermatologist. “These studies further validate the essential benefits of cellular health.”

The study was conducted by researchers from the Dermatest GmbH Institute for Reliable Results.


About ASEA®
ASEA, an emerging global leader in cellular health, is dedicated to providing a sustainable lifestyle by delivering high-quality cellular health products through a principle-based, direct-selling distribution model. Harnessing science, ASEA offers first-to-market products that utilize molecules native to the human body that enhance vital cellular functions. ASEA’s cornerstone, patented redox signaling technology boosts the body’s natural cellular renewal and communication processes, improving total body health and allowing every system of the body to function better. Currently, redox signaling technology is available in two first-to-market products: ASEA® Redox Supplement, the company’s flagship liquid supplement, and RENU 28®, a revitalizing whole-body skin gel. Founded in 2010, ASEA currently operates in 25 international markets. For more information about ASEA products or the accompanying business opportunity, visit ASEA Cellular Health.

About Dermatest GmbH Institute for Reliable Results
Dermatest® was founded in 1978 by Dr. med. Werner Voss, a specialist in dermatology, venerology and allergology. The company has grown steadily over the years, employing highly qualified scientists who are experts in the field of dermatology, thus providing excellent service and generating exceptionally reliable results. For more than 35 years, Dermatest® has offered an extensive portfolio of standard and individual test designs to assess the safety and efficacy of cosmetic products for the cosmetic and pharmaceutical industry. As a company, Dermatest offers specialized solutions and test designs for dermatological, allergological and cosmetic research under dermatological supervision. This guarantees maximum safety for sponsors, customers and test volunteers. The ‘Original Dermatest®’ seal stands as a guarantee for the reproducibility of test methods. Additionally, it provides reassurance for consumers and manufacturers. Dermatest has developed its own quality management system, which has been accredited by the independent German Rhineland TÜV technical inspectorate, TÜV Rheinland, whose role it is to set standards.